Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs.
Stenfors C, Ross SB. Stenfors C, et al. Naunyn Schmiedebergs Arch Pharmacol. 2002 Jun;365(6):462-7. doi: 10.1007/s00210-002-0564-8. Epub 2002 Apr 18. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12070760
Under these conditions (5 mg/kg s.c. reserpine 24 h before the experiment), hypothalamic 5-HT concentration was reduced by more than 97%. In reserpine-treated animals, 5-HT synthesis [measured as the accumulation of 5-hydroxytryptophan (5-HTP) after inhibition of the aroma …
Under these conditions (5 mg/kg s.c. reserpine 24 h before the experiment), hypothalamic 5-HT concentration was reduced by more than …
In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299.
Stenfors C, Werner T, Ross SB. Stenfors C, et al. Naunyn Schmiedebergs Arch Pharmacol. 1998 May;357(5):500-7. doi: 10.1007/pl00005199. Naunyn Schmiedebergs Arch Pharmacol. 1998. PMID: 9650801
The 5-HT1A receptor antagonist, WAY-100,635 competitively inhibited the specific accumulation of 3H-NAD-299 and was about equipotent with unlabelled NAD-299 with ED50 values of 20-30 nmol/kg s.c. ...Spiperone and methiothepin inhibited the 3H-NAD-299 accumulation at 10 mic …
The 5-HT1A receptor antagonist, WAY-100,635 competitively inhibited the specific accumulation of 3H-NAD-299 and was about equipotent with un …
Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists.
Larsson LG, Stenfors C, Ross SB. Larsson LG, et al. Among authors: stenfors c. Eur J Pharmacol. 1998 Apr 10;346(2-3):209-15. doi: 10.1016/s0014-2999(98)00073-9. Eur J Pharmacol. 1998. PMID: 9652362
Both antagonists were significantly more potent in antagonising the effect of 0.30 and 0.76 micromol/kg s.c. 8-OH-DPAT in hippocampus than in hypothalamus, striatum and frontal cortex in mentioned order. ...
Both antagonists were significantly more potent in antagonising the effect of 0.30 and 0.76 micromol/kg s.c. 8-OH-DPAT in hippocampus …
Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo.
Stenfors C, Magnusson T, Larsson LG, Yu H, Hållbus M, Magnusson O, Ross SB. Stenfors C, et al. Naunyn Schmiedebergs Arch Pharmacol. 1999 Feb;359(2):110-6. doi: 10.1007/pl00005329. Naunyn Schmiedebergs Arch Pharmacol. 1999. PMID: 10048595
Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain.
Stenfors C, Yu H, Ross SB. Stenfors C, et al. Neuropharmacology. 2000 Feb 14;39(4):553-60. doi: 10.1016/s0028-3908(99)00173-2. Neuropharmacology. 2000. PMID: 10728876
The in vivo effects of NAS-181 on 5-HT metabolism and synthesis in the rat brain were examined. 5-HT metabolism, measured as the ratio 5-hydroxyindoleacetic acid (5-HIAA)/5-HT, was dose-dependently increased in all four brain regions analysed (hypothalamus, hippocampus, frontal c …
The in vivo effects of NAS-181 on 5-HT metabolism and synthesis in the rat brain were examined. 5-HT metabolism, measured as the ratio 5-hyd …
Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C, Yu H, Ross SB. Stenfors C, et al. Naunyn Schmiedebergs Arch Pharmacol. 2001 Feb;363(2):222-32. doi: 10.1007/s002100000347. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11218075
Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo.
Stenfors C, Ross SB. Stenfors C, et al. Naunyn Schmiedebergs Arch Pharmacol. 2001 Nov;364(5):479-86. doi: 10.1007/s002100100465. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11692232
Pretreatment of mice with 1 mg/kg s.c. reserpine 20 h before the experiment strongly prolonged the dissociation phase for the two ligands. ...In reserpinized mice kept at 30 degrees C 1 h before and during the experiment, which normalised the body temperature, the d …
Pretreatment of mice with 1 mg/kg s.c. reserpine 20 h before the experiment strongly prolonged the dissociation phase for the two lig …
Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine.
Stenfors C, Ross SB. Stenfors C, et al. Life Sci. 2002 Nov 1;71(24):2867-2880. doi: 10.1016/s0024-3205(02)02138-0. Life Sci. 2002. PMID: 12377268
Fluoxetine 6.9 mg/kg s.c. was injected once daily for three weeks. Three days after the final daily injection of fluoxetine 5-HT synthesis (5-HTP accumulation) and turnover (5-HIAA/5-HT ratio) were significantly enhanced compared with saline-treated mice. ...
Fluoxetine 6.9 mg/kg s.c. was injected once daily for three weeks. Three days after the final daily injection of fluoxetine 5-HT synt …
Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist.
Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ryan C, Ross S, Stenfors C. Hudzik TJ, et al. Among authors: stenfors c. J Pharmacol Exp Ther. 2003 Mar;304(3):1072-84. doi: 10.1124/jpet.102.045468. J Pharmacol Exp Ther. 2003. PMID: 12604684
73 results
Jump to page
Feedback